BRCA1/2 testing in minors received mixed parental support

Robson, Mark
July 2008
Hem/Onc Today;7/25/2008, Vol. 9 Issue 13, p26
The article discusses the findings of a study on the attitude of parents on BRCA1/2 mutations testing of minors. The study, which was presented at the American Society of Clinical Oncology (ASCO) Annual Meeting held from May 30 to June 3, 2008, interviewed 153 parents who had undergone BRCA1/2 testing. It found that parents have mixed attitudes toward the administration of such testing in minors.


Related Articles

  • BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years. Robertson, L; Hanson, H; Seal, S; Warren-Perry, M; Hughes, D; Howell, I; Turnbull, C; Houlston, R; Shanley, S; Butler, S; Evans, D G; Ross, G; Eccles, D; Tutt, A; Rahman, N // British Journal of Cancer;3/13/2012, Vol. 106 Issue 6, p1234 

    Background:Triple-negative (TN) tumours are the predominant breast cancer subtype in BRCA1 mutation carriers. Recently, it was proposed that all individuals below 50 years of age with TN breast cancer should be offered BRCA testing. We have evaluated the BRCA1 mutation frequency and the...

  • BRCA testing for familial breast cancer. Chiyan Lau; Suthers, Graeme // Australian Prescriber;Apr2011, Vol. 34 Issue 2, p49 

    Mutations in the BRCA1 and BRCA2 genes are associated with hereditary breast and ovarian cancer. Genetic testing is available in specialised laboratories, but is expensive and presents a significant technical and interpretative challenge. Identification of a causative mutation carries lifelong...

  • Social and ethical implications of BRCA testing. Surbone, A. // Annals of Oncology;Feb2011 Supplement 1, Vol. 22 Issue suppl_1, pi60 

    Oncologists are asked with increasing frequency to counsel their patients with respect to the medical, psychological and social repercussions of genetic testing for cancer susceptibility that may have been prescribed by physicians or carried out through direct-to-consumer tests. This article...

  • SHOULD A FAMILY HAVE TO FACE A UV DILEMMA? Kirk, Claire W.; Morrison, Patrick J. // Ulster Medical Journal;2009, Vol. 78 Issue 1, p65 

    With the advancement of high-throughput technologies for mutation screening, unclassified variants (UV; non-informative mutations for which the pathogenic effect is unclear) are increasingly being discovered in the BRCA1 and BRCA2 genes. There are a number of ways to try to establish the...

  • Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up. Foster, C.; Watson, M.; Eeles, R.; Eccles, D.; Ashley, S.; Davidson, R.; Mackay, J.; Morrison, P. J.; Hopwood, P.; Evans, D. G. R.; Psychosocial Study Collaborators // British Journal of Cancer;3/12/2007, Vol. 96 Issue 5, p718 

    This prospective multicentre study assesses long-term impact of genetic testing for breast/ovarian cancer predisposition in a clinical cohort. Areas evaluated include risk management, distress and insurance problems 3 years post-testing. Participants are adults unaffected with cancer from...

  • Genetic screening for ethnic minorities. Modell, Michael; Modell, Bernadette // BMJ: British Medical Journal (International Edition);6/30/90, Vol. 300 Issue 6741, p1702 

    Focuses on the genetic screening for ethnic minorities at risk of hemoglobin disorders and glucose-6-phosphate dehydrogenase (G6PD) deficiency in Great Britain. Identification of couples at risk of having an affected child; Accuracy of the test to identify carriers of hemoglobin disorders;...

  • Limited Family Structure and BRCA Gene Mutation Status in Single Cases of Breast Cancer. Weitzel, Jeffrey N.; Lagos, Veronica I.; Cullinane, Carey A.; Gambol, Patricia J.; Culver, Julie O.; Blazer, Kathleen R.; Palomares, Melanie R.; Lowstuter, Katrina J.; MacDonald, Deborah J. // JAMA: Journal of the American Medical Association;6/20/2007, Vol. 297 Issue 23, p2587 

    This article offers a study on limited family structure and BRCA gene mutation status in single cases of breast cancer. The objective of the study was to determine if BRCA gene mutations are more prevalent among single cases of early onset breast cancers in families with limited vs. adequate...

  • Is BRCA 1/2 genetic testing cost effective in the USA?  // PharmacoEconomics & Outcomes News;1/21/2012, Issue 645, p6 

    The article reports on the findings by researchers from the University of Rochester School of Medicine that BRCA 1/2 genetic testing of women at high risk of carrying the BRCS 1 or 2 gene mutations, and treatment of those who test positive, seems to be cost effective compared with no genetic...

  • How genetic tests are done.  // Humanities;Mar/Apr97, Vol. 18 Issue 2, p38 

    Discusses how two types of genetic tests are done. Direct test; Linkage test; Test that recognizes tiny alterations or mutations in the DNA of a gene.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics